Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 25, 2005. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
The material changes reported relate to the transfer of Ordinary Shares from the GlaxoSmithKline Employee Trust ("GSK Trust") to plan participants on January 24, 2005:
- 7,907 Ordinary Shares were transferred to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- 1,912 Ordinary Shares were transferred to a participant in the SmithKline Beecham Mid Term Incentive Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document notes that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J D Coombe) hold interests in the shares held by the GSK Trust in the same capacity as other employees.
Investor Verification Points
- Verify the total number of shares transferred from the GSK Trust (9,819 total) against the company's treasury stock records.
- Confirm the specific plans (Employee Share Option Plan 1991 and Mid Term Incentive Plan) under which the shares were distributed.
- Review the full list of directors to confirm the disclosed interests of Dr J-P Garnier, Dr T Yamada, and Mr J D Coombe in the GSK Trust.